The Government of Canada will invest $28.99 million on the new plant “Meltech Innovation Canada” to support local production of the inner filter material used in surgical, pediatric, and N95-type respiratory masks. The new plant will be located in the greater Montreal area and will create at least 21 new jobs and 16 new co-op positions for university students. Given the highly strategic nature of the project, the Government of Canada has committed to investing up to $28.99 million through the Strategic Innovation Fund towards the nearly $39 million investment required.
Quebec-based Medicom Group is establishing the unit and Medicom Group is a leading manufacturer of surgical and respiratory masks. From the first shovel of the earth to produce, the future Meltech plant will be designed to mitigate the impact on the environment. Connected to this plant, Medicom will establish a new research and development center to drive innovation in personal protective equipment (PPE).
Ronald Reuben, CEO, and founder of Medicom said, “This is a great day for medical autonomy in Quebec and Canada. Establishing this new plant that will produce the raw material required for surgical and respiratory masks will help ensure that Canada never again experiences the PPE shortages we did in March 2020 when the global supply chain was under extreme strain. Thanks to this partnership with the Government of Canada, Meltech will initially produce the filter material needed to manufacture the equivalent of tens of millions of masks right here in Canada, with more capacity planned.”
